NEUROHUMORAL MECHANISMS IN GERIATRIC HYPERTENSION: ROLE OF ALDOSTERONE
老年高血压的神经体液机制:醛固酮的作用
基本信息
- 批准号:7376499
- 负责人:
- 金额:$ 2.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-04-05 至 2007-02-28
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to determine if increased levels of a hormone produced in the adrenal gland, aldosterone, plays a part in the increase in blood pressure that is common as people get older. The study is designed to test for interactions between aldosterone and other factors known to be important in high blood pressure in older people. These factors are stiffness of blood vessels, the activity of the sympathetic nervous system (the part of the nervous system that produces the chemical norepinephrine that controls heart rate and blood pressure), insulin, and a relaxing factor produced by blood vessels (nitric oxide). These systems will be tested at the beginning of the study, and again six months later following treatment with one of two medications that are used to treat hypertension. Men and women aged 60 to 80 years will be recruited. To begin the study, systolic blood pressure must be less than 180 (top number) and diastolic blood pressure must be less than 110 (bottom number). Subjects in this study will be randomly assigned (similar to using a coin flip) to take either spironolactone (this medication blocks the effects of aldosterone) or hydrochlorothizide (a diuretic or water pill). This study is important because it will provide new information about the actions of aldosterone that may lead to increased blood pressure in older people, and the potential benefits of treating high blood pressure using an aldosterone blocking medication.
该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子项目和研究者(PI)可能从另一个NIH来源获得主要资金,因此可以在其他CRISP条目中表示。所列机构为中心,不一定是研究者所在机构。这项研究的目的是确定肾上腺中产生的一种激素--醛固酮水平的增加是否在人们变老时常见的血压升高中起作用。这项研究旨在测试醛固酮和其他已知在老年人高血压中重要的因素之间的相互作用。这些因素是血管的硬度,交感神经系统的活动(神经系统的一部分,产生控制心率和血压的化学去甲肾上腺素),胰岛素和血管产生的放松因子(一氧化氮)。这些系统将在研究开始时进行测试,并在六个月后再次使用两种用于治疗高血压的药物之一进行治疗。将招募60至80岁的男性和女性。为了开始研究,收缩压必须低于180(最高数字),舒张压必须低于110(最低数字)。本研究中的受试者将被随机分配(类似于使用抛硬币)服用螺内酯(这种药物阻断醛固酮的作用)或氢氯噻嗪(利尿剂或水丸)。这项研究很重要,因为它将提供有关醛固酮可能导致老年人血压升高的作用的新信息,以及使用醛固酮阻断药物治疗高血压的潜在益处。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mark A Supiano其他文献
Deprescribing for older adults with hypertension at high risk for adverse events: not so fast
对有不良事件高风险的老年高血压患者进行处方精简:别那么快
- DOI:
10.1016/j.lanhl.2024.07.003 - 发表时间:
2024-08-01 - 期刊:
- 影响因子:14.600
- 作者:
Nicholas M Pajewski;Mark A Supiano - 通讯作者:
Mark A Supiano
Mark A Supiano的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mark A Supiano', 18)}}的其他基金
Pulse wave velocity and central aortic pressure outcomes in SPRINT
SPRINT 中的脉搏波速度和中心主动脉压结果
- 批准号:
8528703 - 财政年份:2011
- 资助金额:
$ 2.45万 - 项目类别:
Pulse wave velocity and central aortic pressure outcomes in SPRINT
SPRINT 中的脉搏波速度和中心主动脉压结果
- 批准号:
8711543 - 财政年份:2011
- 资助金额:
$ 2.45万 - 项目类别:
Pulse wave velocity and central aortic pressure outcomes in SPRINT
SPRINT 中的脉搏波速度和中心主动脉压结果
- 批准号:
8214977 - 财政年份:2011
- 资助金额:
$ 2.45万 - 项目类别:
Pulse wave velocity and central aortic pressure outcomes in SPRINT
SPRINT 中的脉搏波速度和中心主动脉压结果
- 批准号:
8326611 - 财政年份:2011
- 资助金额:
$ 2.45万 - 项目类别:
相似海外基金
A cluster randomized controlled trial to evaluate pharmacy-based health promotion program to improve blood pressure control in Bangladesh, India and Pakistan
一项整群随机对照试验,旨在评估孟加拉国、印度和巴基斯坦基于药房的健康促进计划,以改善血压控制
- 批准号:
23K24566 - 财政年份:2024
- 资助金额:
$ 2.45万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Defining a new mechanism of blood pressure regulation and its role during sepsis
定义血压调节的新机制及其在脓毒症期间的作用
- 批准号:
MR/Y011805/1 - 财政年份:2024
- 资助金额:
$ 2.45万 - 项目类别:
Research Grant
Cuffless models to infer blood pressure from bioimpedance
无袖带模型可根据生物阻抗推断血压
- 批准号:
2319920 - 财政年份:2023
- 资助金额:
$ 2.45万 - 项目类别:
Standard Grant
Blood pressure trajectory of inpatient rehabilitation stroke patients from the Determining Optimal Post-Stroke Exercise (DOSE) trial over the first 12-months post-stroke
通过确定最佳中风后运动 (DOSE) 试验得出的中风住院康复患者在中风后 12 个月内的血压轨迹
- 批准号:
493123 - 财政年份:2023
- 资助金额:
$ 2.45万 - 项目类别:
AirPressureNYC: Reducing AIR pollution to lower blood PRESSURE among New York City public housing residents
AirPressureNYC:减少空气污染以降低纽约市公共住房居民的血压
- 批准号:
10638946 - 财政年份:2023
- 资助金额:
$ 2.45万 - 项目类别:
The mechanism of non-dipper blood pressure induced by intermittent hypoxia during sleep
睡眠间歇性缺氧引起非杓型血压的机制
- 批准号:
23K06336 - 财政年份:2023
- 资助金额:
$ 2.45万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Machine Learning Enabled Non-contact Sensing Platform for Blood Pressure and Glucose Prediction
用于血压和血糖预测的机器学习非接触式传感平台
- 批准号:
23K11341 - 财政年份:2023
- 资助金额:
$ 2.45万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
I-Corps: Blood Pressure Monitoring by a Miniaturized Cuffless Sensor
I-Corps:通过小型无袖带传感器进行血压监测
- 批准号:
2332674 - 财政年份:2023
- 资助金额:
$ 2.45万 - 项目类别:
Standard Grant
Blood pressure imaging by contrast enhanced active Doppler ultrasound
通过对比增强主动多普勒超声进行血压成像
- 批准号:
23K18557 - 财政年份:2023
- 资助金额:
$ 2.45万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Central Nervous System Reprogramming of the Control of Blood Pressure Induced by Early Life Stress
早期生活压力引起的血压控制的中枢神经系统重新编程
- 批准号:
10555126 - 财政年份:2023
- 资助金额:
$ 2.45万 - 项目类别:














{{item.name}}会员




